Follow the people · Insider
Gina Mazzariello
Gina Mazzariello files insider transactions with the SEC as a chief legal officer of Amylyx Pharmaceuticals (AMLX). We hold 5 disclosed purchases and sales filed since 28 February 2022, 2 of them in the last 90 days.
- Files forAMLX
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure20 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 February 2022 — 18 August 2026Chief Legal Officer · Amylyx Pharmaceuticals (AMLX)38 Form 4 lines · source: SEC Form 4
Everything they disclosed
38 entries, newest first — one per disclosure report, one per Form 4 line- was granted 21,284 shares of Amylyx PharmaceuticalsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 15,000 shares of Amylyx PharmaceuticalsSEC Form 413 July 2026Common Stock · traded 9 July 2026 · filed 13 July 2026
- ▼ sold on the open market 15,000 shares of Amylyx PharmaceuticalsSEC Form 413 July 2026Common Stock · traded 10 July 2026 · filed 13 July 2026
- was granted 74,660 shares of Amylyx PharmaceuticalsSEC Form 49 March 2026Common Stock · traded 5 March 2026 · filed 9 March 2026
- was granted 111,990 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Stock Option (Right to Buy) · traded 5 March 2026 · filed 9 March 2026
- was granted 111,990 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 49 March 2026Stock Option (Right to Buy) · traded 5 March 2026 · filed 9 March 2026
- was granted 74,660 shares of Amylyx PharmaceuticalsSEC Form 49 March 2026Common Stock · traded 5 March 2026 · filed 9 March 2026
- ▼ sold on the open market 6,844 shares of Amylyx PharmaceuticalsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 6,844 shares of Amylyx PharmaceuticalsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 3,419 shares of Amylyx PharmaceuticalsSEC Form 425 February 2026Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 3,419 shares of Amylyx PharmaceuticalsSEC Form 425 February 2026Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 3,448 shares of Amylyx PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 3,448 shares of Amylyx PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 8,828 shares of Amylyx PharmaceuticalsSEC Form 42 October 2025Common Stock · traded 30 September 2025 · filed 2 October 2025
- ▼ sold on the open market 15,000 shares of Amylyx PharmaceuticalsSEC Form 414 August 2025Common Stock · traded 12 August 2025 · filed 14 August 2025
- ▼ sold on the open market 15,000 shares of Amylyx PharmaceuticalsSEC Form 414 August 2025Common Stock · traded 13 August 2025 · filed 14 August 2025
- gave away 1,000 shares of Amylyx PharmaceuticalsSEC Form 427 May 2025Common Stock · traded 22 May 2025 · filed 27 May 2025
- ▼ sold on the open market 9,192 shares of Amylyx PharmaceuticalsSEC Form 42 April 2025Common Stock · traded 31 March 2025 · filed 2 April 2025
- was granted 95,777 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 410 March 2025Stock Option (right to buy) · traded 6 March 2025 · filed 10 March 2025
- was granted 63,851 shares of Amylyx PharmaceuticalsSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- ▼ sold on the open market 1,611 shares of Amylyx PharmaceuticalsSEC Form 45 March 2025Common Stock · traded 3 March 2025 · filed 5 March 2025
- ▼ sold on the open market 4,169 shares of Amylyx PharmaceuticalsSEC Form 426 February 2025Common Stock · traded 24 February 2025 · filed 26 February 2025
- ▼ sold on the open market 3,678 shares of Amylyx PharmaceuticalsSEC Form 45 February 2025Common Stock · traded 3 February 2025 · filed 5 February 2025
- ▼ sold on the open market 8,709 shares of Amylyx PharmaceuticalsSEC Form 42 October 2024Common Stock · traded 30 September 2024 · filed 2 October 2024
- ▼ sold on the open market 10,455 shares of Amylyx PharmaceuticalsSEC Form 416 May 2024Common Stock · traded 15 May 2024 · filed 16 May 2024
- was granted 110,000 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 418 April 2024Stock Option (right to buy) · traded 16 April 2024 · filed 18 April 2024
- was granted 80,560 shares of Amylyx PharmaceuticalsSEC Form 418 April 2024Common Stock · traded 16 April 2024 · filed 18 April 2024
- ▼ sold on the open market 1,540 shares of Amylyx PharmaceuticalsSEC Form 47 March 2024Common Stock · traded 5 March 2024 · filed 7 March 2024
- was granted 55,000 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 428 February 2024Stock Option (right to buy) · traded 26 February 2024 · filed 28 February 2024
- was granted 36,667 shares of Amylyx PharmaceuticalsSEC Form 428 February 2024Common Stock · traded 26 February 2024 · filed 28 February 2024
- ▼ sold on the open market 2,838 shares of Amylyx PharmaceuticalsSEC Form 427 February 2024Common Stock · traded 23 February 2024 · filed 27 February 2024
- ▼ sold on the open market 6,164 shares of Amylyx PharmaceuticalsSEC Form 417 August 2023Common Stock · traded 15 August 2023 · filed 17 August 2023
- gave away 500 shares of Amylyx PharmaceuticalsSEC Form 419 May 2023Common Stock · traded 17 May 2023 · filed 19 May 2023
- was granted 82,500 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 420 March 2023Stock Option (right to buy) · traded 16 March 2023 · filed 20 March 2023
- was granted 18,333 shares of Amylyx PharmaceuticalsSEC Form 420 March 2023Common Stock · traded 16 March 2023 · filed 20 March 2023
- ▼ sold on the open market 3,586 shares of Amylyx PharmaceuticalsSEC Form 428 February 2023Common Stock · traded 24 February 2023 · filed 28 February 2023
- was granted 182,000 shares of Amylyx Pharmaceuticals (a derivative holding)SEC Form 428 February 2022Stock Option (right to buy) · traded 22 February 2022 · filed 28 February 2022
- was granted 41,000 shares of Amylyx PharmaceuticalsSEC Form 428 February 2022Common Stock · traded 22 February 2022 · filed 28 February 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.